Arquivos do dia: Julho 8, 2021
Coorte nacional prospectiva no Chile mostrou que a efetividade da CoronaVac foi de 65,9% para Covid-19 sintomática, 87,5% para hospitalizações, 90,3% para admissões em UTI e 86,3% para mortes.
8 Jul, 2021 | 09:57hEffectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile – New England Journal of Medicine
Relacionado: Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years. E WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic. E Brazilian town experiment shows mass vaccination can wipe out COVID-19.
Comentário no Twitter
Chile's data on Sinovac CoronaVac in NEJM: not controlled study. Model details pic 2
– doses 28 days apart (like Serrana trial)
– symptomatic disease 65.9% (65-67)
– hospitalization 87.5% (87-88)
– intensive care 90.3% (89-91)
– Covid death 86.3% (85-88)
https://t.co/CB1U8Ar163 pic.twitter.com/4HwASRCnwQ— Hilda Bastian, PhD (@hildabast) July 7, 2021
Série de casos | Plasmaférese em 3 pacientes com trombocitopenia trombótica imune induzida por vacina.
8 Jul, 2021 | 09:56h
Comentário no Twitter
Three patients with severe manifestations of VITT after #COVID19 vaccination had poor response to initial therapy with anticoagulants and intravenous immune globulin. Their condition improved after therapeutic plasma exchange was initiated.
— NEJM (@NEJM) July 7, 2021
Novas evidências sugerem que a vacina Sputnik contra COVID é segura e eficaz.
8 Jul, 2021 | 09:55hMounting evidence suggests Sputnik COVID vaccine is safe and effective – Nature
COVID e escolas: evidências para a reabertura segura.
8 Jul, 2021 | 09:54hCOVID and schools: the evidence for reopening safely – Nature
Educação durante a COVID-19: recomendações do European Technical Advisory Group.
8 Jul, 2021 | 09:53hResistência antibiótica durante e depois da COVID-19.
8 Jul, 2021 | 09:52hAntibiotic resistance during and beyond COVID-19 – JAC-Antimicrobial Resistance
Perspectiva | Pessoas com problemas imunológicos deveriam tomar uma 3ª dose de vacina?
8 Jul, 2021 | 09:51hShould People With Immune Problems Get Third Vaccine Doses? – The New York Times (poucos artigos gratuitos por mês)
Relacionado: [Preprint] 3rd AstraZeneca shot gives strong immunity. E Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.
Relatório preliminar do Consenso ADA | Tratamento do diabetes tipo 1 em adultos.
8 Jul, 2021 | 09:50hThe Management of Type 1 Diabetes in Adults — A Consensus Report by the ADA and EASD
Comentários: ADA/EASD Draft Guidance Aims to Bring Adults With Type 1 Diabetes Out of Shadows – Medscape (necessário cadastro gratuito) E New consensus report on adults with type 1 diabetes focuses on individualised care – Diabetes Times
Revisão | Recomendações dietéticas para prevenção de aterosclerose.
8 Jul, 2021 | 09:49hDietary recommendations for prevention of atherosclerosis – Cardiovascular Research
Comunicado de imprensa: What should I eat to avoid heart disease? – European Society of Cardiology
Comentário: Plant-Based Diet Best for Your Heart – HealthDay
Revisão | Suporte ventilatório não invasivo e cateter nasal de alto fluxo como tratamentos de primeira linha na insuficiência respiratória hipoxêmica aguda e na síndrome da angústia respiratória aguda (SARA).
8 Jul, 2021 | 09:48h
Comentário no Twitter
Physiology-to-bedside overview about non-invasive ventilatory support in AHRF & #ARDS
➡️spontaneous breathing: benefits/harms
➡️how to make spontaneous effort non‑injurious?
➡️optimizing HFNO & NIV
➡️monitoring to detect failure & be protective
➡️evidencehttps://t.co/KPW2u8akhA pic.twitter.com/yKVxrYaFmZ— Intens Care Med (@yourICM) July 7, 2021